Estrogen binding to the ER initiates cyclin D transcription, followed by activation of the CDK4/6-RB1 pathway.360–362 Hence, dysregulation of the CDK4/6-RB1 pathway is a significant feature of hormone receptor (HR)-positive breast cancers.363. Here, RB1 is linked to breast cancer.